Suzanne Louise Bruhn - Mar 3, 2025 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
Director
Signature
/s/ Michael Cohen, Attorney-in-Fact
Stock symbol
VIGL
Transactions as of
Mar 3, 2025
Transactions value $
$0
Form type
4
Date filed
3/4/2025, 05:09 PM
Previous filing
Jun 17, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Stock Option Award (Right to Buy) Award $0 +33.9K $0.00 33.9K Mar 3, 2025 Common Stock 33.9K $2.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option award was issued pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of cash compensation, and the shares subject to this award vest and become exercisable in four equal quarterly installments on the last day of each calendar quarter occurring hereafter, with the first installment vesting on March 31, 2025.